Cd2Ap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CD2AP (CD2-Associated Protein) is an adaptor protein that links signaling receptors to the cytoskeleton. It plays critical roles in immune cell function, podocyte architecture, and neuronal function. Genetic variants in CD2AP are associated with increased risk for Alzheimer's disease and certain forms of neurodegeneration.
CD2AP (also known as CIN85 in humans) is a scaffolding protein that interacts with various receptors and signaling molecules. In the brain, it is involved in synaptic function, protein quality control, and cellular stress responses. Its role in Alzheimer's disease has garnered significant research interest.
CD2AP is a 639 amino acid adaptor protein:
CD2AP is expressed in neurons and other cell types:
CD2AP is an AD risk gene:
Genetic Association: rs9349407
Mechanisms:
CD2AP in synapses:
CD2AP-Aβ relationship:
CD2AP in protein clearance:
| Strategy | Status | Notes |
|---|---|---|
| CD2AP modulators | Discovery | Modulate expression |
| Protein-protein interaction | Research | SH3 domain targeting |
| Gene therapy | Preclinical | Increase expression |
The study of Cd2Ap Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] CD2AP genetic association with AD. PMID:22875137
[2] CD2AP regulates synaptic function. PMID:23555257
[3] CD2AP in amyloid pathology. PMID:24353159
[4] CD2AP in protein quality control. PMID:25649656